Author:
Montoya J.J.,Rubio J.M.,Ouahid Y.,Lopez A.,Madejon A.,Gil-Garcia A.I.,Hannam R.J.,Butler H.R.E.,Castan P.
Abstract
AbstractBackground and aimsQuick, user-friendly and sensitive diagnostic tools are the key to controlling the spread of the SARS-CoV-2 pandemic in the new epidemiologic landscape. The aim of this work is to characterise a new Covid-19 antigen test that uses an innovative chromatographic Affimer®-based technology designed for the qualitative detection of SARS-CoV-2 antigen. As rapid technology to detect Covid-19, the test was extensively characterised in vitro. Once the analytical parameters of performance were set, the test system was challenged in a test field study. The aim of this study was to evaluate its diagnostic accuracy, as compared by the gold standard RT-PCR and other existing lateral flow tests.
Publisher
Cold Spring Harbor Laboratory
Reference17 articles.
1. World Health Organization. Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays: interim guidance, 11 September 2020. WHO/2019-nCoV/Antigen_Detection/2020.1. Geneva: World Health Organization; 2020.
2. Rethinking Covid-19 Test Sensitivity — A Strategy for Containment
3. Federal Institute for Drugs and Medical Devices. Antigen-Tests auf SARS-CoV-2. Bonn: Federal Institute for Drugs and Medical Devices; 2021 [cited 2021 Jun 7]. https://www.bfarm.de/DE/Medizinprodukte/Antigentests/_node.html.
4. Krüger LJ , Gaeddert M , Köppel L , Brümmer LE , Gottschalk C , Miranda IB , et al. Evaluation of the accuracy, ease of use and limit of detection of novel, rapid, antigen-detecting point-of-care diagnostics for SARS-CoV-2. medRxiv. 2020 Oct 4.
5. Promise versus Reality: Optimism Bias in Package Inserts for Tuberculosis Diagnostics